Strengthening Kenya’s vaccine manufacturing readiness requires sustained technical engagement, strategic collaboration, and shared expertise. Kenya BioVax Institute was pleased to host Mr. Frederik Kristensen, Managing Director, Dr. Michael Lusiola, Director, and Ms. Emmanuelle Naud, Senior Project Manager, from the Regionalized Vaccine Manufacturing Collaborative (RVMC) during their visit to the Embakasi site for the planned fill-and-finish facility. The delegation engaged BioVax’s technical team on project progress, technical requirements, and strategic opportunities linked to advancing local vaccine manufacturing capacity in Kenya.
The engagement further strengthened dialogue on sustainable vaccine production, regional manufacturing readiness, and the partnerships required to advance health security in Kenya and across Africa.
